+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Passive Immunizing Drugs against Rabies Market - Global Forecast 2026-2032- Product Image
Passive Immunizing Drugs against Rabies Market - Global Forecast 2026-2032- Product Image
Sale

Passive Immunizing Drugs against Rabies Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134348
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Passive Immunizing Drugs against Rabies Market is projected to reach USD 872.05 Million in 2026. It is expected to continue growing at a CAGR of 7.42%, reaching USD 1.33 Billion by 2032.

Introduction to Passive Immunizing Drugs Against Rabies

Passive immunizing drugs against rabies, including rabies immunoglobulins and related antibody-based products, are used with post-exposure vaccination for people potentially exposed to rabies virus. Their clinical value is highest when wounds are promptly assessed, thoroughly managed, and infiltrated with the appropriate product according to local protocols. Access depends on emergency-care readiness, reliable cold-chain and stock management, trained clinicians, regulatory authorization, and coordination between human and veterinary health services.

How Rabies Prevention Is Being Transformed

The landscape is shifting from isolated product availability toward integrated post-exposure systems. Earlier exposure recognition, standardized wound care, electronic reporting, decentralized emergency services, and stronger One Health surveillance can reduce delays between exposure and treatment. Product development is also emphasizing consistent potency, safety, easier administration, and supply resilience, while public-health programs increasingly connect vaccination of dogs and other reservoirs with human post-exposure care.

Artificial Intelligence’s Role in Rabies Prevention and Treatment

Artificial intelligence can support rabies control by helping triage exposure reports, identify geographic patterns, prioritize vaccination and outreach, and detect potential shortages from logistics data. Clinical decision-support tools may improve adherence to wound-care and immunoglobulin protocols, but they require validated datasets, transparent governance, cybersecurity safeguards, and clinician oversight. AI should complement-not replace-laboratory confirmation, professional risk assessment, and established treatment guidance.

Regional Insights Across Rabies-Prevention Systems

North America generally benefits from established emergency-care and surveillance infrastructure, while maintaining the need for rapid access in remote areas. Latin America’s priorities include strengthening rural delivery, integrating dog vaccination, and reducing treatment delays. Europe emphasizes coordinated standards, surveillance, and cross-border preparedness. The Middle East faces varied access conditions and the need for dependable referral pathways. Africa continues to require stronger availability, affordability, diagnostic capacity, and community awareness. Asia-Pacific combines substantial exposure burdens in some settings with major opportunities from urban animal-control programs, expanded health coverage, and digital surveillance.

Group-Level Priorities for Coordinated Rabies Control

ASEAN cooperation can improve cross-border surveillance, procurement coordination, and clinical training across diverse health systems. BRICS members can contribute to manufacturing resilience, research collaboration, and approaches suited to large and geographically varied populations. The European Union can reinforce harmonized guidance, supply coordination, and surveillance interoperability. G7 countries can support innovation, financing, and technical assistance for global access. GCC systems can strengthen centralized procurement, emergency referral networks, and workforce readiness. NATO members can incorporate rabies preparedness into medical logistics and operational health planning where relevant.

Country Insights on Access and Preparedness

Australia’s priorities include remote-area access and wildlife-exposure assessment. Brazil and Mexico need sustained integration of human treatment with dog vaccination and municipal surveillance. Canada and the United States must maintain rapid access across rural and frontier settings. China and India require broad, timely post-exposure services alongside large-scale prevention and reporting systems. Japan and South Korea emphasize preparedness, standardized clinical practice, and management of imported exposures. France, Germany, Italy, Spain, and the United Kingdom can focus on coordinated guidance, surveillance, and dependable emergency supply. Russia faces the importance of geographically distributed access, veterinary coordination, and continuity across remote regions.

Actions for Leaders in Rabies Immunization

Leaders should map treatment access by travel time and exposure risk, maintain auditable buffer-stock policies, and train emergency clinicians in wound infiltration and referral procedures. They should pair human post-exposure programs with dog vaccination, bite-prevention education, and veterinary surveillance. Procurement strategies should address product quality, alternative suppliers, temperature-controlled logistics, and contingency distribution. Digital tools should improve case reporting and inventory visibility while protecting personal data. Performance monitoring should track treatment timeliness, protocol adherence, adverse events, stock interruptions, and outcomes across underserved populations.

Research Methodology for the Executive Summary

This summary applies a structured, evidence-oriented framework to passive immunizing drugs against rabies. It considers clinical use in post-exposure prophylaxis, health-system requirements, regulatory and procurement conditions, One Health coordination, regional variation, and the potential role of artificial intelligence. Insights are synthesized qualitatively from established public-health and clinical principles, with attention to differences in epidemiology, infrastructure, geography, and access. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: Strengthening Timely Rabies Post-Exposure Protection

Effective use of passive immunizing drugs against rabies depends on more than the product itself. Timely exposure assessment, correct wound management, vaccination, reliable supply, trained personnel, and coordinated surveillance must work together. Regional and country strategies should prioritize equitable emergency access while expanding animal vaccination and prevention. Carefully governed digital and AI-enabled tools can improve coordination, but resilient public-health systems and professional clinical judgment remain central to preventing fatal disease.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Passive Immunizing Drugs against Rabies Market, by Product Type
7.1. Introduction
7.2. Formulation
7.2.1. Liquid Form
7.2.2. Lyophilized Form
8. Passive Immunizing Drugs against Rabies Market, by Route Of Administration
8.1. Introduction
8.2. Intramuscular Injection
8.3. Intravenous Injection
8.4. Wound Infiltration
9. Passive Immunizing Drugs against Rabies Market, by Application
9.1. Introduction
9.2. Postexposure Prophylaxis
9.3. Preexposure Prophylaxis
10. Passive Immunizing Drugs against Rabies Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Passive Immunizing Drugs against Rabies Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Research Institutes
12. Passive Immunizing Drugs against Rabies Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Passive Immunizing Drugs against Rabies Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Passive Immunizing Drugs against Rabies Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. CSL Limited
16.2. Grifols S.A.
16.3. Haffkine Bio-Pharmaceutical Corporation Limited
16.4. Kamada Ltd.
16.5. Kedrion S.p.A.
16.6. Les Laboratoires Français du Fractionnement et des Biotechnologies (LFB)
16.7. Octapharma AG
16.8. Serum Institute of India Private Limited
16.9. Shandong Taibang Biopharmaceutical Co., Ltd.
16.10. Takeda Pharmaceutical Company Limited
16.11. Tianjin Kinghem Pharmaceutical Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Passive Immunizing Drugs against Rabies Market, Years Considered for the Study
FIGURE 2. Global Passive Immunizing Drugs against Rabies Market, Research Design
FIGURE 3. Global Passive Immunizing Drugs against Rabies Market, Research Framework
FIGURE 4. Global Passive Immunizing Drugs against Rabies Market, Data Triangulation
FIGURE 5. Global Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Passive Immunizing Drugs against Rabies Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Passive Immunizing Drugs against Rabies Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Passive Immunizing Drugs against Rabies Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Passive Immunizing Drugs against Rabies Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Passive Immunizing Drugs against Rabies Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Passive Immunizing Drugs against Rabies Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Passive Immunizing Drugs against Rabies Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Passive Immunizing Drugs against Rabies Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Passive Immunizing Drugs against Rabies Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Passive Immunizing Drugs against Rabies Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Passive Immunizing Drugs against Rabies Market Segmentation & Coverage
TABLE 2. Global Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 3. Global Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Formulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Formulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Formulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid Form Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid Form Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid Form Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Lyophilized Form Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Lyophilized Form Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Lyophilized Form Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 14. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Intravenous Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Intravenous Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Intravenous Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Wound Infiltration Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Wound Infiltration Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Wound Infiltration Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Postexposure Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Postexposure Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Postexposure Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Preexposure Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Preexposure Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Preexposure Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 31. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 58. North America Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. North America Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 60. North America Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 61. North America Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 62. North America Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. North America Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 64. North America Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Latin America Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Latin America Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 67. Latin America Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 68. Latin America Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 69. Latin America Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Latin America Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 71. Latin America Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Europe Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Europe Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Europe Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 75. Europe Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 76. Europe Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Europe Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Europe Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Middle East Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Middle East Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Middle East Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 82. Middle East Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 83. Middle East Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Middle East Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Middle East Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Africa Passive Immunizing Drugs against Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Africa Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Africa Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 89. Africa Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 90. Africa Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Africa Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Africa Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Global Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 97. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 98. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. ASEAN Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. ASEAN Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. GCC Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. GCC Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. GCC Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 104. GCC Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 105. GCC Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. GCC Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. GCC Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. European Union Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. European Union Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. European Union Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 111. European Union Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. European Union Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. European Union Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. European Union Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. BRICS Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. BRICS Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 118. BRICS Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 119. BRICS Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. BRICS Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. BRICS Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. G7 Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. G7 Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. G7 Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 125. G7 Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 126. G7 Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. G7 Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. G7 Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. NATO Passive Immunizing Drugs against Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. NATO Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. NATO Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 132. NATO Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. NATO Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. NATO Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. NATO Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Global Passive Immunizing Drugs against Rabies Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. United States Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 138. United States Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. United States Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 140. United States Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 141. United States Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. United States Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. United States Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Canada Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 145. Canada Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Canada Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 147. Canada Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 148. Canada Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Canada Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Canada Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Mexico Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 152. Mexico Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Mexico Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 154. Mexico Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 155. Mexico Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Mexico Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Mexico Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Brazil Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 159. Brazil Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Brazil Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 161. Brazil Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 162. Brazil Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Brazil Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Brazil Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. United Kingdom Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 166. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 168. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. United Kingdom Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Germany Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 173. Germany Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Germany Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 175. Germany Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 176. Germany Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Germany Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Germany Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. France Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 180. France Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. France Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 182. France Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 183. France Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. France Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. France Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Russia Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 187. Russia Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Russia Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 189. Russia Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. Russia Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Russia Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. Russia Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Italy Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 194. Italy Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. Italy Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 196. Italy Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 197. Italy Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Italy Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Italy Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Spain Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 201. Spain Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Spain Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 203. Spain Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 204. Spain Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Spain Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Spain Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. China Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 208. China Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. China Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 210. China Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. China Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. China Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. China Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. India Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 215. India Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. India Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 217. India Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 218. India Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. India Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. India Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Japan Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 222. Japan Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Japan Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 224. Japan Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. Japan Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Japan Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. Japan Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Australia Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 229. Australia Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Australia Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 231. Australia Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. Australia Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Australia Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Australia Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. South Korea Passive Immunizing Drugs against Rabies Market Size, 2017-2032 (USD Million)
TABLE 236. South Korea Passive Immunizing Drugs against Rabies Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. South Korea Passive Immunizing Drugs against Rabies Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 238. South Korea Passive Immunizing Drugs against Rabies Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. South Korea Passive Immunizing Drugs against Rabies Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. South Korea Passive Immunizing Drugs against Rabies Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. South Korea Passive Immunizing Drugs against Rabies Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Global Passive Immunizing Drugs against Rabies Market Share, by Key Player, 2025
TABLE 243. Global Passive Immunizing Drugs against Rabies Market, Key Experts

Companies Mentioned

  • CSL Limited
  • Grifols S.A.
  • Haffkine Bio-Pharmaceutical Corporation Limited
  • Kamada Ltd.
  • Kedrion S.p.A.
  • Les Laboratoires Français du Fractionnement et des Biotechnologies (LFB)
  • Octapharma AG
  • Serum Institute of India Private Limited
  • Shandong Taibang Biopharmaceutical Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Kinghem Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Anti-Rabies Serum Market Report 2026 - Product Image

Anti-Rabies Serum Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Baygam Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Baygam Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Neglected Tropical Diseases Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Neglected Tropical Diseases Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Rabies Treatment - Global Strategic Business Report - Product Image

Rabies Treatment - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Neglected Tropical Disease Treatment Market - Global Forecast 2026-2032 - Product Image

Neglected Tropical Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.